One tablet contains 25 mg of Cainnarazinum (cinnarizine).
Excipient of known effect: lactose monohydrate 115 mg.
Treatment of ventricular disorders and Meniere’s disease, such as vertigo, nausea, vomiting.
Prevention of motion sickness.
Treatment of symptoms of cerebral (e.g. vertigo, tinnitus, headache)
and peripheral circulation (e.g. intermittent claudication, Raynaud’s disease).
Hypersensitivity to cinnarizine or any of the excipients.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
One tablet contains 25 mg of Cainnarazinum (cinnarizine).
Excipient of known effect: lactose monohydrate 115 mg.
Treatment of ventricular disorders and Meniere’s disease, such as vertigo, nausea, vomiting.
Prevention of motion sickness.
Treatment of symptoms of cerebral (e.g. vertigo, tinnitus, headache)
and peripheral circulation (e.g. intermittent claudication, Raynaud’s disease).
Hypersensitivity to cinnarizine or any of the excipients.
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
